Goat Anti-Llama IgG H&L (HRP) (ab112786)
Key features and details
- Goat Anti-Llama IgG H&L (HRP)
- Conjugation: HRP
- Host species: Goat
- Isotype: IgG
- Suitable for: WB, ELISA, ICC, IHC-P
Related conjugates and formulations
Overview
-
Product name
Goat Anti-Llama IgG H&L (HRP)
See all IgG secondary antibodies -
Host species
Goat -
Target species
Llama -
Specificity
ab112786 reacts specifically with Llama IgG and with light chains common to other Llama immunoglobulins. No antibody was detected against nonimmunoglobulin serum proteins. -
Tested applications
Suitable for: WB, ELISA, ICC, IHC-Pmore details -
Conjugation
HRP
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 6.8
Constituents: 0.2% BSA, 0.05% CMIT/MIT based preservative -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Purification notes
ab112786 was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to HRP. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Related Products
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab112786 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
1/1000 - 1/30000. Colorimetric: 1/1000-1/10000. Chemiluminescent: 1/1000-1/30000.
|
|
ELISA | (1) |
1/10000 - 1/100000.
|
ICC |
1/200 - 1/500.
|
|
IHC-P |
1/200 - 1/500.
|
Notes |
---|
WB
1/1000 - 1/30000. Colorimetric: 1/1000-1/10000. Chemiluminescent: 1/1000-1/30000. |
ELISA
1/10000 - 1/100000. |
ICC
1/200 - 1/500. |
IHC-P
1/200 - 1/500. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (9)
ab112786 has been referenced in 9 publications.
- Liu H et al. Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice. Cell Rep Med 4:100918 (2023). PubMed: 36702124
- Südfeld C et al. The nucleolus as a genomic safe harbor for strong gene expression in Nannochloropsis oceanica. Mol Plant 15:340-353 (2022). PubMed: 34775107
- Van Fossen EM et al. Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins. Front Chem 10:835229 (2022). PubMed: 35265586
- Kamel M et al. Non-Invasive Detection of SARS-CoV-2 Antigen in Saliva versus Nasopharyngeal Swabs Using Nanobodies Conjugated Gold Nanoparticles. Trop Med Infect Dis 7:N/A (2022). PubMed: 35736981
- Marino M et al. AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model. EMBO Mol Med 14:e09824 (2022). PubMed: 35352880
- Szurgot I et al. DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice. Sci Rep 11:3125 (2021). PubMed: 33542325
- Gavira-O'Neill CE et al. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research. Curr Protoc Neurosci 94:e107 (2020). PubMed: 33185319
- Ou K et al. A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse. Animals (Basel) 10:N/A (2020). PubMed: 32796682
- Calpe S et al. Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors. MAbs 8:678-88 (0). WB . PubMed: 26967714